VMI-CFA

Clinical Trial Investigating the Efficacy of the Supera Peripheral Stent System for the Treatment of the Common Femoral Artery
Repair medicine
Research
Innovation

Full title of the trial

VMI-CFA Study: Physician-initiated Trial Investigating the Efficacy of the Vascular Mimetic Implant Supera Peripheral Stent System for the Treatment of the Common Femoral Artery

Objective(s) of the trial

The VMI-CFA study investigates the efficacy of the Supera Stent in the treatment of common femoral artery stenosis or occlusion. 100 patients will be included with a RF of 2 to 4.

The lesion is located within the native CFA and treated with predillation prior to stenting with the Supera Peripheral Stent System.

Patients will be invited for a follow-up visit at 1, 6 and 12 month post procedure. The primary endpoint of the  study is the primary patency at 12 months and periprocedural events up to 30 days post procedure. Secondary endpoints include technical success, primary patency rate at 1 & 6 month, freedom from TLR at 1-, 6- and 12 month follow-up and clinical success at 1-, 6- & 12-month follow-up.

Trial status

Recruiting